The FDA has flagged emideltide/DSIP in a compounding safety-risk context because of insufficient safety information and concerns involving peptide impurities and immunogenicity, while existing human studies are too small and short-term to reliably assess long-term adverse effects
Product details: Product name: GLOW Composition: BPC-157 / TB-500 / GHK-Cu blend Product type: Combined research peptide material Intended application: Laboratory, analytical, and in-vitro research Testing: Third-party tested SKU: GLOW70 Handle, store, and dispose of this material according to established laboratory procedures and applicable regulations
Pregnant or breastfeeding individuals should consult their healthcare provider to determine the most appropriate treatment plan
Disclaimer: AOD-9604 is intended strictly for laboratory research and in-vitro use only
BPC 157 has some great benefits, but there are always potential side effects with medical treatments that you should consider
Keep peptide and solvent vial tops clean